As per MRFR analysis, the India High Throughput Screening Market Size was estimated at 0.93 USD Billion in 2024. The India High Throughput Screening Market Industry is expected to grow from 1.02 USD Billion in 2025 to 3.02 USD Billion by 2035.
The India High Throughput Screening Market CAGR growth rate is expected to be around 10.351% during the forecast period 2025 - 2035.
The India High Throughput Screening Market is witnessing significant growth influenced by various key market drivers. Increasing investment in drug discovery and development by both governmental institutions and private sectors, along with the rise of biotechnology companies in India, is driving the adoption of high throughput screening HTS technologies.
The Indian government has made strides in supporting biotechnology through initiatives like ‘Make in India’ and the National Biotechnology Development Strategy, fostering an environment conducive to innovation and growth. Opportunities to be explored in this market include collaboration between research institutions and pharmaceutical companies to enhance drug discovery processes.
This collaboration can increase efficiency and reduce costs, thereby making the technology more accessible to smaller firms in the country. Recent trends show a growing focus on automation and data analysis in HTS as researchers strive for quicker and more accurate screening processes. With advancements in technology, particularly artificial intelligence and machine learning, there is potential for greater efficiencies in processing and interpreting high volumes of data generated through HTS.
Additionally, a significant trend is the shift towards personalized medicine in India, necessitating the need for more advanced screening techniques that can cater to individual genetic profiles. The increasing prevalence of chronic diseases in India further boosts the demand for high throughput screening as researchers seek innovative therapeutic solutions.
Overall, the convergence of these drivers and trends highlights a dynamic and rapidly evolving landscape for the high throughput screening market in India.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The India High Throughput Screening Market Industry is experiencing significant growth driven by the increasing demand for drug discovery. With the rise in chronic diseases like cancer, diabetes, and cardiovascular conditions, pharmaceutical companies are investing heavily in Research and Development R&D to find new treatment options.
According to the Indian Council of Medical Research ICMR, the prevalence of diabetes in India is projected to rise to 134 million by 2045, emphasizing a critical need for novel therapeutic approaches. Major organizations such as Sun Pharmaceutical Industries and Cipla Ltd. are leading the way in utilizing throughput screening technologies to expedite the drug discovery process, thus enhancing the market for high-throughput screening solutions.
This growing pharmaceutical focus is a strong driver for the demand high throughput screening tools and technologies in India.
The Government of India is significantly boosting the India High Throughput Screening Market Industry through various initiatives and funding for biotechnology and pharmaceutical research. The Department of Biotechnology DBT has launched numerous programs aimed at enhancing innovation in drug development. For instance, the Biotechnology Industry Research Assistance Council BIRAC provides funding and support to biotech firms, facilitating the use of high throughput screening technologies.
Also, the recently published National Biotechnology Development Strategy aims to greatly improve the revenue generated from the biotech industry. This starts giving a positive atmosphere for high-throughput screening to develop in India. Such state support is very important for increasing the possibilities of development in this branch.
There is a notable increase in investments within the genomics and biotechnology sectors, which are driving the India High Throughput Screening Market Industry forward. In the past few years, there has been a surge of investments from both domestic and international investors in India's biotechnology landscape.
For instance, the Indian biotechnology sector attracted over USD 1.6 billion in investments in 2021, reflecting a growing interest in innovative therapeutic solutions. Companies like Biocon and Wockhardt are leveraging high throughput screening methodologies to enhance their genetic research and product development capabilities.
This rise in investment is creating a substantial demand for throughput screening technologies that support advanced biological research and drug development.
The India High Throughput Screening Market encompasses an extensive range of products and services that play a crucial role in the fields of drug discovery and biotechnology. This market has been supported by governmental initiatives aimed at boosting Research and Development in life sciences and pharmaceuticals, which in turn enhances the demand for various offerings.
Reagents and assay kits are significant components in this segment, as they are essential in biochemistry for performing a multitude of tests and determining the efficacy of compounds. Instruments tailored for high throughput screening enable laboratories to conduct numerous tests simultaneously, significantly expediting the research process, while consumables and accessories support the day-to-day operations necessary to maintain high efficiency and accuracy.
Software solutions for data analysis and management are becoming increasingly important as the volume of generated data from screening processes rises, providing scientists with tools to interpret results effectively. Additionally, associated services, including maintenance, training, and support, contribute to enhancing the overall performance of high throughput screening platforms, ensuring that laboratories can operate at optimal levels.
The segment exhibits a diverse landscape with many stakeholders, therefore creating various opportunities for growth as the biotechnology sector expands in India. The integration of advanced technologies, such as artificial intelligence and machine learning, further adds a layer of complexity and drives innovation within this segment. Collectively, the Product and Service segment within the India High Throughput Screening Market reflects a dynamic interplay of various offerings that cater to the evolving needs of biomedical research and industry, fostering an environment ripe for advancements in drug discovery and therapeutics.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Technology segment of the India High Throughput Screening Market is crucial for facilitating advanced drug discovery and development processes across various industries. Cell-Based Assays play a prominent role by enabling real-time cellular observations and quick screening capabilities, making them indispensable in Research and Development activities.
In particular, the 2D Cell Culture method is widely utilized for its simplicity and cost-effectiveness, while the emerging 3D Cell Culture technology fosters a more accurate representation of in vivo environments, enhancing the reliability of results. Furthermore, innovative Scaffold-Based and Scaffold-free Technologies are gaining traction as they offer diverse approaches to cell growth and interaction, laying important foundations for understanding cellular mechanisms.
Hanging-drop Plates and Ultra-low Binding Plates provide specialized solutions for fostering cell cultures with minimal interference, which is vital for validating high-throughput methodologies. The robustness and adaptability of these technologies drive significant advancements in the India High Throughput Screening Market, as they cater to the evolving needs of pharmaceutical companies and biotech firms amidst growing competition and research demands.
The rapid growth of biopharmaceutical research combined with increasing investments in healthcare contributes to the overall expansion of this market segment in India.
The India High Throughput Screening Market is increasingly becoming competitive as various players seek to capitalize on the growing demand for drug discovery, biotechnology research, and personalized medicine. The market is marked by a blend of established companies and emerging players that aim to leverage advanced technologies and innovations in high-throughput screening, which is pivotal in identifying potential drug candidates at a faster pace and with greater efficiency.
Factors such as rising investment in research and development, a focus on automation, and the increasing need for innovative therapeutic solutions are driving growth and enhancing competition among key market participants. The growing collaboration between public and private sectors further complements the expansion of this market, leading to opportunities for more growth and technological advancements.
Tecan Group holds a significant position in the India High Throughput Screening Market thanks to its robust product portfolio and strong reputation in laboratory automation and liquid handling solutions. The company is known for its innovative technologies that facilitate efficient workflows in drug discovery and other research activities. With a well-established distribution network in India, Tecan Group has successfully positioned itself to cater to the increasing demand for high-throughput systems that streamline the screening process.
Their strengths lie in offering customizable solutions, comprehensive customer support, and a commitment to advancing laboratory efficiencies. Furthermore, Tecan Group's emphasis on partnerships and collaborations with research institutions in India enhances its competitive advantage and ability to respond proactively to market needs.
Danaher Corporation is also a formidable player in the India High Throughput Screening Market, offering a wide range of products and services that cater to the needs of life sciences and diagnostics. The company's portfolio includes highly advanced instruments, consumables, and software solutions that are pivotal in drug discovery processes.
Danaher enjoys a strong market presence in India, bolstered by its focus on innovation and consistent investment in research and development. The company has embarked on several mergers and acquisitions to enhance its capabilities and extend its reach in the Indian market, making it well-positioned to adapt to rapidly changing industry demands.
Additionally, Danaher's diverse offerings in the realm of high-throughput screening demonstrate its strengths in providing integrated solutions that address the complexities of drug development, reinforcing its competitiveness in this evolving landscape.
The India High Throughput Screening Market has witnessed significant developments recently, especially with increasing investments in biotechnology and pharmaceutical sectors. In August 2023, Merck KGaA announced plans to expand its footprint in India, focusing on enhancing its screening technologies. Abbott Laboratories launched new automation solutions aimed at high throughput screening applications in July 2023, increasing efficiency for laboratories.
The market has shown a growth trend, with companies like Thermo Fisher Scientific and Tecan Group reporting substantial revenue increases due to demand for advanced screening technologies. In terms of mergers, Danaher Corporation and Sartorius are known to be strategically positioning themselves in India, but no significant acquisitions have been publicly disclosed as of now.
Over the past two years, the Indian government’s initiatives to boost the biotechnology industry, along with the increase in Research and Development funding, have positively impacted the high throughput screening market, projecting potential expansions in infrastructure and technological capabilities. Companies active in this space are responding to these favorable conditions, leading to enhanced competition and innovation within the market.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 0.93(USD Billion) |
| MARKET SIZE 2024 | 1.02(USD Billion) |
| MARKET SIZE 2035 | 3.02(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 10.351% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Tecan Group, Danaher Corporation, Abbott Laboratories, Merck KGaA, Fisher Scientific, Sartorius, Johnson & Johnson, Promega Corporation, BioRad Laboratories, Becton Dickinson, PerkinElmer, SigmaAldrich, Agilent Technologies, Thermo Fisher Scientific, Corning |
| SEGMENTS COVERED | Product & Service, Technology |
| KEY MARKET OPPORTUNITIES | Rising demand for personalized medicine, Growth in biopharmaceutical research, Advancements in automation technologies, Increased funding for drug discovery, Expansion of academic research initiatives |
| KEY MARKET DYNAMICS | increased drug discovery activities, growth in biotechnology research, technological advancements in automation, rising prevalence of chronic diseases, expansion of pharmaceutical industry |
| COUNTRIES COVERED | India |
Frequently Asked Questions (FAQ) :
The India High Throughput Screening Market is expected to be valued at 1.02 USD Billion in 2024.
The market is projected to reach a value of 3.02 USD Billion by 2035.
The expected CAGR for the India High Throughput Screening Market from 2025 to 2035 is 10.351%.
Major players in this market include Tecan Group, Danaher Corporation, Abbott Laboratories, and Merck KGaA among others.
The Reagents segment is projected to hold the largest market share, valued at 0.35 USD Billion in 2024.
The Assay Kits Instruments segment is expected to grow to 0.7 USD Billion by 2035.
The Consumables segment is anticipated to experience significant growth, reaching 0.53 USD Billion by 2035.
Emerging trends such as advanced technology incorporation and increasing demand for drug discovery processes present significant opportunities.
Challenges include high costs of equipment and the need for skilled personnel to operate high throughput screening technologies.
Rising research activities and pharmaceutical developments in regions like India boost the market demand and overall size significantly.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
